Cite
Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a survey across Europe
MLA
Jorgensen, M. H., et al. Children with Autoimmune Liver Disease Have Limited Access to Age-Appropriate Drug Formulations, Results from a Survey across Europe. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..40e69b46a5dcb4921f42c263569e6bcf&authtype=sso&custid=ns315887.
APA
Jorgensen, M. H., Canazi, M., Buescher, G., Samyn, M., & Ruth De Bruyne. (2022). Children with autoimmune liver disease have limited access to age-appropriate drug formulations, results from a survey across Europe.
Chicago
Jorgensen, M. H., M. Canazi, G. Buescher, M. Samyn, and Ruth De Bruyne. 2022. “Children with Autoimmune Liver Disease Have Limited Access to Age-Appropriate Drug Formulations, Results from a Survey across Europe,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..40e69b46a5dcb4921f42c263569e6bcf&authtype=sso&custid=ns315887.